Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

298
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
298
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

379
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
379
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

424
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
424
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

854
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
854
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.3K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.3K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

323
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
323

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study.

Aging cell·2026
Same author

RxnBench: A Multimodal Benchmark for Evaluating Large Language Models on Chemical Reaction Understanding from the Scientific Literature.

Journal of chemical information and modeling·2026
Same author

Identification and Evaluation of Conserved Subunit Vaccine Candidates Conferring Cross-Serotype Protection Against <i>Streptococcus suis</i> Serotypes 2, 7, 8, and 9.

Transboundary and emerging diseases·2026
Same author

RIVER delivers multimodal gene-directed regulatory interactions across diverse biological contexts with broad application potentials.

Science China. Life sciences·2026
Same author

NMR-Solver: automated structure elucidation via large-scale spectral matching and physics-guided fragment optimization.

Nature communications·2026
Same author

A dual-functional nanoplatform based on pH-driven self-assembly of pea protein isolate-folic acid conjugate for targeted and stabilized delivery of curcumin.

Food research international (Ottawa, Ont.)·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same journal

Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor.

Journal of chemical information and modeling·2026
Same journal

PACEff Builder: An Efficient Platform for Constructing PACE Hybrid-Resolution Models for Molecular Dynamics Simulations of Aqueous Protein, Peptide Assembly, and Membrane Protein Systems.

Journal of chemical information and modeling·2026
Same journal

TransKla: A Local-Global Cross-Attention Based Transformer Approach for Prediction of Lysine Lactylation Sites.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

走向可概括的数据驱动药理学与可解释的神经ODEs.

Yaning Cui1, Xiaohong Ji1, Wentao Guo1,2

  • 1DP Technology, Beijing 100089, China.

Journal of chemical information and modeling
|February 25, 2026
PubMed
概括
此摘要是机器生成的。

一个新的神经框架Uni-PK通过整合分子数据和个体因素,准确地建模药物度-时间概况. 这种方法提高了个性化药物的药理动力学预测,减少了动物试验.

更多相关视频

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

相关实验视频

Last Updated: Feb 26, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.5K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.1K

科学领域:

  • 药理动力学和计算生物学
  • 药物开发和精准医学 药物开发和精准医学
  • 医疗保健中的人工智能

背景情况:

  • 准确的药物度-时间 (C-t) 概况建模对于药物开发和个性化剂量至关重要.
  • 传统的药理动力学 (PK) 模型面临着由于刚性假设和广泛的参数化而导致的可扩展性和适应性的局限性.
  • 需要先进的建模方法,可以有效地处理各种化合物和患者群体.

研究的目的:

  • 引入Uni-PK,一个统一的神经框架,用于端到端的药理动力学建模.
  • 开发一种可扩展和可解释的解决方案,用于预测药物度动态.
  • 通过结合个体间的变异性,实现个性化的临床前和临床应用.

主要方法:

  • 通过在 PK 结构中将分子表示与神经普通微分方程 (NODE) 结合起来,开发了 Uni-PK.
  • 采用灵活的上下文编码器来整合辅助共变量 (例如,物种,剂量方案) 以进行个性化建模.
  • 从分子和个体输入中实现药物度的直接动态轨迹建模,促进在数据稀缺条件下学习.

主要成果:

  • Uni-PK在各种管理途径和生理状态的老鼠和人类数据集上表现出强的表现.
  • 该框架显示与已确定的药理动力学原理一致,验证了其机械基础.
  • 实现端到端的学习能力,即使在数据稀缺和杂的条件下,也优于传统方法.

结论:

  • Uni-PK为下一代药理动力学建模提供了一个可扩展,可解释和节省动物的解决方案.
  • 化学结构和个体特定信息的整合促进了精密治疗.
  • 这种统一的神经框架有可能对药物开发和个性化剂量策略产生重大影响.